Summary & Overview
CPT 88312: Special Stain with Interpretation and Report, Group I
CPT code 88312 covers special stains, including interpretation and reporting, for Group I stains commonly used in pathology laboratories. This code is critical for the identification of microorganisms and tissue elements, such as those found in infectious diseases or certain malignancies, supporting precise clinical diagnosis. Nationally, the code is recognized by major payers including Aetna, Blue Cross Blue Shield, Cigna Health, Medicare, and UnitedHealthcare, ensuring broad coverage for pathology services.
Readers will gain insight into the clinical context of 88312, including its role in laboratory diagnostics, typical sites of service, and the importance of both technical and professional components. The publication also provides benchmarks, policy updates, and an overview of related codes and modifiers, offering a comprehensive understanding of how this code fits into the broader landscape of pathology billing and reimbursement. Key ICD-10 diagnoses associated with 88312 include conditions such as tuberculosis, HIV disease, pneumonia, candidal stomatitis, and aspergillosis, highlighting its relevance in infectious disease diagnostics. The summary also addresses related CPT codes and taxonomies, equipping readers with essential information for navigating pathology billing and coding.
CPT Code Overview
CPT code 88312 is used to report special stains, including interpretation and report, for Group I stains such as Gridley and acid fast. This procedure is a part of Pathology and Laboratory Procedures, specifically performed in a laboratory setting. Both the technical and professional components are typically involved, reflecting the comprehensive nature of the service. Special stains are essential for identifying specific microorganisms or tissue elements, supporting accurate diagnosis and patient management.
Clinical & Coding Specifications
Clinical Context
A patient presents with respiratory symptoms and a lung biopsy is performed to investigate possible infectious or inflammatory disease. The specimen is sent to the laboratory, where a pathologist orders special stains such as Gridley or acid-fast stains to identify organisms like mycobacteria or fungi. The pathologist interprets the stained slides and issues a report detailing the findings. This workflow is typical for patients suspected of having conditions such as tuberculosis, HIV-related infections, pneumonia, candidiasis, or aspergillosis, where special stains are necessary to aid in diagnosis.
Coding Specifications
-
Modifiers:
- Modifier
26: Used when reporting only the professional component (interpretation and report) of the service. - Modifier
TC: Used when reporting only the technical component (preparation and staining of slides) of the service.
- Modifier
-
Provider Taxonomies:
Taxonomy Code Specialty Name 207ZP0102XAnatomic Pathology & Clinical Pathology 207ZP0101XCytopathology 207ZP0007XPathology
These taxonomies represent providers specializing in pathology, including anatomic, clinical, and cytopathology.
Related Diagnoses
-
A15.0: Tuberculosis of lung- Relevant for cases where acid-fast stains are used to detect Mycobacterium tuberculosis in lung tissue.
-
B20: Human immunodeficiency virus [HIV] disease- Special stains may be required to identify opportunistic infections in HIV-positive patients.
-
J18.9: Pneumonia, unspecified organism- Special stains help determine the causative organism in pneumonia when routine stains are inconclusive.
-
B37.0: Candidal stomatitis- Gridley or other fungal stains are used to detect Candida species in oral tissue samples.
-
B44.9: Aspergillosis, unspecified- Special stains are necessary to identify Aspergillus species in tissue, aiding diagnosis of aspergillosis.
Related CPT Codes
88313: Special stain including interpretation and report; group II. Used for stains not included in group I, often performed alongside88312for comprehensive evaluation.88321: Consultation and report on referred material and/or preparation of slides. Utilized when a second opinion or review of slides is needed, may be used in conjunction with88312.88322: Consultation and report on referred material and/or preparation of slides. Similar to88321, used for additional consultations.88323: Consultation and report on referred material and/or preparation of slides. Used for further review or consultation.88324: Consultation and report on referred material and/or preparation of slides. Applied in extended consultation scenarios.88325: Consultation and report on referred material and/or preparation of slides. Used for complex cases requiring multiple consultations.
Codes 88321 through 88325 are related to consultations and may be used together with 88312 when material is referred for additional review. 88313 is commonly used as an alternative or complement to 88312 for different types of special stains.
National Reimbursement Benchmarks
Medicare's national mean rate for CPT 88312 is $76.23, closely aligned with the BUCA (average commercial) mean rate of $76.01. Among commercial payers, Aetna and Blue Cross Blue Shield have higher mean rates at $85.65 and $81.92, respectively, while Cigna and UnitedHealth Group are lower at $72.87 and $72.41.
Rate dispersion varies significantly across payers. Blue Cross Blue Shield exhibits the widest spread, with a difference of $63.67 between its 75th and 25th percentiles. In contrast, UnitedHealth Group shows the tightest range, with only $34.00 separating its 75th and 25th percentiles. This indicates greater consistency in UnitedHealth Group's rates compared to Blue Cross Blue Shield.
The table and chart below present a detailed breakdown of national benchmarks for each payer.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.